Patents by Inventor Mi Emily Zeng

Mi Emily Zeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GPR142 agonist compounds
    Patent number: 9861613
    Abstract: The present invention provides compounds of the Formula (Ia) wherein R is selected from the group consisting of CH3, CH(CH3)2, CH2CN, CH2CHF2, CH2CF3, (A), (B), (C), (D), (E), (F), CH2CH2OCH3, and CH2C(O)OCH(CH3)2; R1 is selected from the group consisting of CF3, OCF3, and Cl; R2 is selected from the group consisting of H and F; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: January 9, 2018
    Assignee: Eli Lilly and Company
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Emily Zeng, Jingye Zhou
  • GPR142 Agonist Compounds
    Publication number: 20170165234
    Abstract: The present invention provides compounds of the Formula (Ia) wherein R is selected from the group consisting of CH3, CH(CH3)2, CH2CN, CH2CHF2, CH2CF3, (A), (B), (C), (D), (E), (F), CH2CH2OCH3, and CH2C(O)OCH(CH3)2; R1 is selected from the group consisting of CF3, OCF3, and Cl; R2 is selected from the group consisting of H and F; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 22, 2015
    Publication date: June 15, 2017
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Emily Zeng, Jingye Zhou